Skip to main content

Simlandi 40 mg/0.4 mL single-dose autoinjector Images

Generic Name: adalimumab

This medication has been identified as Simlandi 40 mg/0.4 mL single-dose autoinjector. It is supplied by Teva Pharmaceuticals USA, Inc.

Simlandi is used in the treatment of Ankylosing Spondylitis; Crohn's Disease; Crohn's Disease, Maintenance; Crohn's Disease, Active; Hidradenitis Suppurativa and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Simlandi 40 mg/0.4 mL single-dose autoinjector is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Simlandi 40 mg/0.4 mL single-dose autoinjector medicine

Simlandi

Generic Name
adalimumab
Strength
40 mg/0.4 mL single-dose autoinjector
Availability
Prescription only
Drug Class
TNF alfa inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Manufacturer
Alvotech USA Inc.
National Drug Code (NDC)
51759-0402

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.